Nicotinamide Riboside — Safety, Research, Risks & Legal Status

Not medical advice. Nicotinamide Riboside is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.

Also known as	NR, Niagen, NAD+ precursor
Category	Supplement
nad_precursor	True
branded_form	Niagen
developer	ChromaDex
human_trials_available	True
US legal status	Sold as a dietary supplement (DSHEA) in the USA. Not FDA-approved as drug. Widely available over-the-counter. Purity, bioavailability, and potency vary by brand.

What is Nicotinamide Riboside?

A form of vitamin B3 and NAD+ precursor that supports cellular energy and mitochondrial function. Metabolized to NAD+ via salvage pathways. Like NMN, aims to restore age-related NAD+ decline.

How it works

NR is converted to NMN via nicotinamide riboside kinase (NRK), then to NAD+ via salvage pathways. NAD+ supports sirtuins (metabolic regulation), PARPs (DNA repair), and CD38 (immune signaling). Better oral bioavailability than NMN in some models.

Background & history

NR identified as NAD+ precursor ~2004. Studied extensively for aging and metabolic disease. More human data than NMN; Niagen (ChromaDex) is commercial branded form. Multiple clinical trials conducted 2016-present.

What the research says

Preclinical rodent data show improved mitochondrial function and metabolic markers. Multiple human trials (most 4-12 weeks) report improved mitochondrial respiration, exercise capacity, and metabolic parameters. Evidence is encouraging but limited; long-term efficacy and safety in humans are unclear.

Reported effects

Studied for increased blood and cellular NAD+ levels
Research suggests improved mitochondrial respiration in older adults
Preclinical and small human studies on metabolic rate and exercise capacity
Animal models show anti-aging potential; human evidence limited
Possible improvement in endothelial function and vascular health
Proposed benefits for muscle strength and endurance in aging

Dosing & administration (informational)

Clinical trials range 250-2000 mg daily. No optimal dose established. Typical supplement doses 250-500 mg; bioavailability and absorption variable.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

Well-tolerated in clinical trials (typically 4-12 weeks duration)
Mild GI upset, headache reported in some trials
Long-term safety in humans not established
Potential interaction with sirtuin activators (resveratrol) unknown
Product quality and purity vary; many lack third-party testing
Flushing and vasodilation reported at high doses (B3-related)

Drug & supplement interactions

Resveratrol: both proposed sirtuin activators; synergistic effects unknown
AMPK activators (metformin, thiazolidinediones): NAD+ pathway overlap
NAD+-consuming enzymes (PARPs, CD38): potential functional interactions
B3 supplements (niacin, niacinamide): additive; may increase flushing
Alcohol: both affect NAD+ metabolism; interaction unclear

Who should avoid it

Severely impaired liver or kidney function
Active chemotherapy or cancer treatment (NAD+ role in tumor metabolism)
Pregnancy (insufficient long-term safety data)
Concurrent high-dose niacin (B3 toxicity risk)
Patients with gout or elevated uric acid (B3-related effects)

How it is commonly combined

NR with NMN is redundant; not recommended. Can stack with AMPK activators (metformin) or sirtuin modulators (resveratrol) but efficacy and safety of combinations untested in humans.

Legal & regulatory. Sold as a dietary supplement (DSHEA) in the USA. Not FDA-approved as drug. Widely available over-the-counter. Purity, bioavailability, and potency vary by brand.

Quality & harm reduction

V
e
r
i
f
y
t
h
i
r
d
-
p
a
r
t
y
C
O
A
;
p
u
r
i
t
y
s
h
o
u
l
d
e
x
c
e
e
d
9
8
%
.
B
i
o
a
v
a
i
l
a
b
i
l
i
t
y
v
a
r
i
e
s
b
y
f
o
r
m
a
n
d
i
n
d
i
v
i
d
u
a
l
;
a
b
s
o
r
p
t
i
o
n
n
o
t
g
u
a
r
a
n
t
e
e
d
.
N
i
a
g
e
n
i
s
b
r
a
n
d
e
d
f
o
r
m
f
r
o
m
C
h
r
o
m
a
D
e
x
;
g
e
n
e
r
i
c
N
R
v
a
r
i
e
s
i
n
q
u
a
l
i
t
y
.
G
M
P
m
a
n
u
f
a
c
t
u
r
i
n
g
i
m
p
o
r
t
a
n
t
;
c
o
u
n
t
e
r
f
e
i
t
s
e
x
i
s
t
.

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options

Frequently asked questions

Is nicotinamide riboside better than nicotinamide mononucleotide (NMN)?

Both are NAD+ precursors with similar proposed mechanisms. NR has more published human trials; NMN is newer with less human data. Neither has clear superiority.

Does NR actually increase NAD+ in humans?

Clinical trials show NR increases blood NAD+ markers. Whether tissue-level NAD+ improves and translates to functional benefit is less clear.

Is NR a vitamin or drug?

NR is a vitamin (B3 analog) and dietary supplement in the USA. It is not FDA-approved as a drug and does not have a drug indication.

Can NR prevent or reverse aging?

Aging is shown in animal models; no human lifespan studies exist. Marketing claims of age-reversal are speculative and not evidence-based.

What about B3 toxicity from NR?

At supplement doses (250-500 mg), NR does not approach niacin toxicity levels. High-dose flushing is unlikely; serious hepatic toxicity risk is minimal.

References & further reading

ChromaDex/Niagen clinical trial data and publications
Multiple academic NAD+ and aging research groups
B3 metabolism and NAD+ salvage pathway biochemistry
Supplement efficacy reviews and independent testing organizations